Botox and other weakening agents may be good alternative to the invasive TOS surgery. But BOTOX is limited by his short action.

ricin-mAb35

http://www.ncbi.nlm.nih.gov/pubmed/1...?dopt=Abstract
http://www.ncbi.nlm.nih.gov/pubmed/11867584

corticotropin releasing factor (CRF) or antibody to insulin growth factor I–receptor (anti-IGFIR) + BOTOX

http://www.iovs.org/content/52/2/982.long

doxorubicin

http://www.ncbi.nlm.nih.gov/pubmed/11994969
http://www.ncbi.nlm.nih.gov/pubmed/3192375
http://www.ncbi.nlm.nih.gov/pubmed/7775121

To be continued...